Ocrelizumab-induced colitis and cytomegalovirus infection and their disadvantageous interaction with underlying multiple sclerosis
Zeitschrift für Gastroenterologie · 01.11.2023 · 61 (11) · 1500-1503
DOI: 10.1055/a-2008-0979 ↗Kurz gefasst
Fallbericht in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.11.2023. Verfasst von Sabine Lieb und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dept. of Hepatology, University of Leipzig, Leipzig, Germany. Hauptthemen laut MEDLINE: Multiple Sclerosis, Colitis, Cytomegalovirus Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Ocrelizumab is a humanized monoclonal antibody against the B-lymphocyte antigen CD20 and the only approved treatment option in primary progressive multiple sclerosis. Herpesvirus-related infections like cytomegalovirus (CMV) infections are common in patients receiving ocrelizumab, whereas gastrointestinal side effects with inflammatory bowel disease (IBD) like esophagitis or colitis are very rare. This case report describes the challenging clinical, endoscopic, and histologic features of an ocrelizumab-induced colitis overlapping with CMV infection and their disadvantageous interaction with the underlying multiple sclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dept. of Hepatology, University of Leipzig, Leipzig, Germany.
- Dept. of Gastroenterology, University of Leipzig, Leipzig, Germany.
- Helios Klinik Leisnig, Leisnig, Germany.
- Institute of Pathology, University of Leipzig, Leipzig, Germany.
Zitieren
APA
Lieb, S., Heni, M., Rauschenberg, S., Lange, K., Feisthammel, J., Bläker, H., & Wiegand, J. (2023). Ocrelizumab-induced colitis and cytomegalovirus infection and their disadvantageous interaction with underlying multiple sclerosis. Zeitschrift für Gastroenterologie, 61(11), 1500-1503. https://doi.org/10.1055/a-2008-0979
Vancouver
Lieb S, Heni M, Rauschenberg S, Lange K, Feisthammel J, Bläker H, et al. Ocrelizumab-induced colitis and cytomegalovirus infection and their disadvantageous interaction with underlying multiple sclerosis. Zeitschrift für Gastroenterologie. 2023;61(11):1500-1503. doi:10.1055/a-2008-0979
BibTeX
@article{Lieb2023,
author = {Lieb, Sabine and Heni, Maria and Rauschenberg, Sophie and Lange, Kay and Feisthammel, Juergen and Bläker, Hendrik and Wiegand, Johannes},
title = {Ocrelizumab-induced colitis and cytomegalovirus infection and their disadvantageous interaction with underlying multiple sclerosis},
journal = {Zeitschrift für Gastroenterologie},
year = {2023},
volume = {61},
number = {11},
pages = {1500--1503},
doi = {10.1055/a-2008-0979}
}
EUVIMED